ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 24 analysts with an average price target of $21.8. This is a potential upside of $7.21 (49.42%) from yesterday's end of day stock price of $14.59.

ACADIA Pharmaceuticals's activity chart (see below) currently has 304 price targets and 279 ratings on display. The stock rating distribution of ACAD is 35.35% HOLD, 63.64% BUY and 1.01% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.42% with an average time for these price targets to be met of 211.28 days.

Highest price target for ACAD is $42, Lowest price target is $19, average price target is $21.8.

Most recent stock forecast was given by DAVID HOANG from CITI on 08-Aug-2024. First documented stock forecast 06-May-2013.

Currently out of the existing stock ratings of ACAD, 35 are a HOLD (35.35%), 63 are a BUY (63.64%), 1 are a SELL (1.01%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$23

$8.13 (54.67%)

$30

2 months 1 days ago

0/3 (0%)

$7.28 (46.31%)

Buy

$27

$12.13 (81.57%)

$27

2 months 1 days ago

8/21 (38.1%)

$11.28 (71.76%)

119

Buy

$20

$5.13 (34.50%)

$28

2 months 2 days ago

16/21 (76.19%)

$4.83 (31.84%)

184

Buy

$28

$13.13 (88.30%)

$30

2 months 2 days ago

0/3 (0%)

$12.83 (84.57%)

Buy

$28

$13.13 (88.30%)

$37

2 months 2 days ago

25/36 (69.44%)

$12.83 (84.57%)

486

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 211.28 days on average for the stock forecasts to be realized with a an average price target met ratio 66.42

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 3 price targets and 2 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $45.13

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$2.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?